Karuna extends selloff while Wall Street backs schizophrenia candidate

USA Recession and Crashing Economy Concept


Karuna Therapeutics (NASDAQ:KRTX) dropped for the second straight session on Tuesday to reach a seven-month low, while Wall Street brushed off safety results in a Phase 3 readout for its schizophrenia candidate KarXT, co-developed with Zai Lab Limited (